Reference
Liu Q, et al. Pembrolizumab-associated ocular myasthenia gravis. Clinical and Experimental Ophthalmology 47: 796-798, No. 6, Aug 2019. Available from: URL: http://doi.org/10.1111/ceo.13499 - Australia
Rights and permissions
About this article
Cite this article
Pembrolizumab. Reactions Weekly 1769, 354 (2019). https://doi.org/10.1007/s40278-019-67368-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-67368-9